The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Share News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Triad hails recovery; Alpha Group profit tops outlook

Wed, 18th Jan 2023 14:54

(Alliance news) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

--------

Alpha Group International PLC - London-based provider of financial solutions - Expects 2022 revenue to increase by 27% to about GBP98 million, up from GBP77.5 million a year ago. Expects operating profit to be in line with expectations and pretax profit to be ahead. "These results have been achieved alongside increased investment in our people, infrastructure, and technology, in particular within our Alternative Banking Solutions division, where client demand continues to exceed our expectations," it explains.

--------

Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Expects lower-than-expected revenue and significant back-end phasing of orders in financial 2023, but a stronger opening order book for financial 2024. Notes "several headwinds" impacting its ability to fulfil orders ahead of year-end on March 31. Says its current order book is GBP2.5 million, and further orders are expected, but says a number of orders will move into financial 2024. Full-year revenue from the Health & Nutrition business is now expected between GBP7.5 million to GBP8.0 million for the year ended March 31. This will result in a loss before interest, tax, depreciation and amortisation from continuing operations of around GBP1.0 million, Omega explains.

--------

STM Group PLC - London-based cross border financial services provider - Expects 2022 revenue to be GBP24.1 million. Earnings before interest, tax, depreciation and amortisation are expected to be no less than GBP3.2 million, with pretax profit to be not less than GBP1.7 million. "New business for the second half of the year remained steady albeit slower than anticipated, particularly within the personal pensions and life assurance business, and measures are being implemented to address this," it adds.

--------

Triad Group PLC - Godalming, England-based software and consultancy - Notes the "speed and vigour" of its recovery from "extraordinary" delays experienced for months during the summer of 2022. The Says it is now looking forward to a "very strong" fourth quarter. This will also likely be the basis for a "successful" following year.

--------

Crimson Tide PLC - Tunbridge Wells-based software developer - Says full-year revenue will exceed GBP5.3 million, up 30% from GBP4.1 million a year ago. "It is pleasing that the increased performance at the top line will result in a smaller-than-expected loss at the Ebitda level, despite the deployment of investment capital in marketing and growth," it says. Expects pretax loss to be smaller than expected due to "the enhanced sales figures and our decision to be cautious in marketing spend in the second half".

By Xindi Wei, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
7 Sep 2020 14:50

IN BRIEF: Omega Diagnostics Completes AbC-19 Self-Test Usability Study

IN BRIEF: Omega Diagnostics Completes AbC-19 Self-Test Usability Study

Read more
3 Sep 2020 18:15

IN BRIEF: Omega Diagnostics Reports CE-Mark Of Mologic Covid-19 Test

IN BRIEF: Omega Diagnostics Reports CE-Mark Of Mologic Covid-19 Test

Read more
3 Sep 2020 11:38

Omega prepares to manufacture Mologic Covid-19 test

(Sharecast News) - Medical diagnostics company Omega announced on Thursday that it has CE-marked Mologic's lateral flow antibody test for Covid-19, for sale under its 'Visitect' brand.

Read more
21 Aug 2020 10:18

WHO Prequalification For Omega Diagnostics' HIV Advanced Disease Test

WHO Prequalification For Omega Diagnostics' HIV Advanced Disease Test

Read more
19 Aug 2020 16:00

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
30 Jul 2020 13:23

Omega Diagnostics up on CE-marking of Covid test

(Sharecast News) - Omega Diagnostics updated the market on the work of the UK Rapid Test Consortium in the development of a Covid-19 'Abc-19' lateral flow antibody test on Thursday, reporting that lead partner Abingdon Health has CE-marked the test for professional use.

Read more
14 Jul 2020 16:11

Omega Diagnostics Swings To Loss In Full Year Despite Revenue Growth

Omega Diagnostics Swings To Loss In Full Year Despite Revenue Growth

Read more
8 Jul 2020 15:51

IN BRIEF: Omega Diagnostics Issues 54% Of Shares Under Open Offer

IN BRIEF: Omega Diagnostics Issues 54% Of Shares Under Open Offer

Read more
8 Jul 2020 10:01

Omega Diagnostics completes open offer to raise £11m

(Sharecast News) - Omega Diagnostics reported the results of its open offer on Wednesday, netting gross proceeds from its recent fundraising of £11m before expenses.

Read more
2 Jul 2020 10:32

IN BRIEF: Omega Diagnostics Near Antibody Test Green Light In India

IN BRIEF: Omega Diagnostics Near Antibody Test Green Light In India

Read more
2 Jul 2020 09:26

Omega Diagnostics' ELISA antibody test gets approval in India

(Sharecast News) - Medical diagnostics company Omega revealed on Thursday that its CE-Marked Mologic ELISA antibody test had been approved for Covid-19 testing in India.

Read more
29 Jun 2020 16:43

IN BRIEF: Omega Diagnostics Reports Progress At Virus Consortium

IN BRIEF: Omega Diagnostics Reports Progress At Virus Consortium

Read more
29 Jun 2020 11:40

Omega upbeat on Covid test consortium developments

(Sharecast News) - Omega Diagnostics updated the market on an announcement from the UK Rapid Test Consortium (UK-RTC) on Monday, developing a Covid-19 lateral flow antibody test that could be used by people in their homes.

Read more
19 Jun 2020 10:56

Omega Diagnostics To Raise Up To GBP11 Million To Develop Products

Omega Diagnostics To Raise Up To GBP11 Million To Develop Products

Read more
9 Jun 2020 14:16

Omega expands Covid testing work, stops allergy development

(Sharecast News) - Omega Diagnostics updated the market on a number of fronts on Tuesday, announcing the signing of a longer-term supply agreement with Mologic, first orders for the Covid-19 'ELISA' test, and the signing of an additional material transfer agreement with Mologic.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.